drugset / Trial / NCT00754767

L-Carnitine L-Tartrate in Preventing Peripheral Neuropathy Caused By Chemotherapy in Women With Metastatic Breast Cancer

NCT00754767

Phase 4 Terminated 2 enrolled HealthPartners Institute
RandomizedSingle-groupDouble-blindSupportive care

Summary

RATIONALE: L-carnitine L-tartrate may prevent peripheral neuropathy caused by chemotherapy. PURPOSE: This randomized clinical trial is studying how well L-carnitine L-tartrate works in preventing peripheral neuropathy caused by chemotherapy in women with metastatic breast cancer.

Timeline

Start
2007-01-02
Primary completion
2008-04-02
Completion
2008-05-02

Drugs

EvaluationDrugModalityDoseRoute
Subject L-carnitine Other / unclassified Oral